全迷走神經刺激設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全迷走神經刺激設備市場預計將從2025年的6.7億美元成長至2034年的16.5億美元，2026年至2034年的複合年成長率（CAGR）為10.56%。該市場成長勢頭強勁，主要得益於癲癇、憂鬱症和焦慮症等神經和精神疾病盛行率的不斷上升。迷走神經刺激設備是一種先進的醫療設備，它透過向迷走神經傳遞電脈衝來幫助調節大腦活動和控制症狀。神經刺激療法作為一種有效的治療選擇被廣泛接受，是推動市場成長的主要因素。

推動這一市場發展的因素包括醫療保健成本上升、人們對神經系統疾病的認知提高以及醫療技術的進步。人口老化加劇，老年人更容易罹患這些疾病，這也是市場擴張的主要動力。此外，正在進行的研究和臨床試驗正在探索迷走神經刺激的新治療應用，從而拓展其潛在用途。

未來，市場預計將在設備設計和功能方面不斷創新，從而改善患者的治療效果和舒適度。與數位健康平台的整合將有助於更好地進行監測和個人化治療。新興市場應用範圍的擴大以及醫療專業人員日益成長的支持將推動市場進一步成長。迷走神經刺激設備市場預計在未來幾年將迎來顯著成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全迷走神經刺激設備市場：依產品類型分類

• 市場分析、洞察與預測
• 嵌入式
• 非侵入性（tVNS）

第5章：全迷走神經刺激設備市場：依應用分類

• 市場分析、洞察與預測
• 疼痛管理
• 癲癇發作
• 肥胖管理
• 憂鬱症與焦慮症
• 其他

第6章：全迷走神經刺激設備市場：依生物材料分類

• 市場分析、洞察與預測
• 陶瓷
• 金屬
• 聚合物

第7章 全迷走神經刺激設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心（ASC）
• 其他

第8章 全迷走神經刺激設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 對中東和非洲市場的分析、洞察和預測。
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • ReShape Lifesciences Inc
  • LivaNova LLC
  • ElectroCore Inc
  • MicroTransponder Inc
  • Parasym Ltd
  • Cerebral Inc
  • Cerbomed GmbH
  • Neuvana LLC
  • Nevro Corp
  • NeuroPace Inc

The global vagus nerve stimulator market size is expected to reach USD 1.65 Billion in 2034 from USD 0.67 Billion in 2025, growing at a CAGR of 10.56 during 2026-2034.This market is gaining momentum due to the increasing prevalence of neurological and psychiatric disorders such as epilepsy, depression, and anxiety. Vagus nerve stimulators are advanced medical devices that deliver electrical impulses to the vagus nerve, helping regulate brain activity and manage symptoms. The growing acceptance of neurostimulation therapies as effective treatment options is significantly contributing to market growth.

The market is driven by factors such as rising healthcare expenditure, increasing awareness about neurological disorders, and advancements in medical technology. The aging population, which is more susceptible to such conditions, is also a major contributor to market expansion. Furthermore, ongoing research and clinical studies are exploring new therapeutic applications of vagus nerve stimulation, expanding its potential use cases.

Looking ahead, the market is expected to witness continuous innovation in device design and functionality, improving patient outcomes and comfort. Integration with digital health platforms will enable better monitoring and personalized treatment approaches. Increasing adoption in emerging markets and growing support from healthcare providers will further drive growth. The vagus nerve stimulator market is poised for significant development in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Implantable
• Non-invasive (tVNS)

By Application

• Pain Management
• Epileptic Seizures
• Obesity Management
• Depression and Anxiety
• Others

By Biomaterial

• Ceramics
• Metallic
• Polymeric

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

COMPANIES PROFILED

• ReShape Lifesciences Inc., LivaNova LLC, electroCore Inc., MicroTransponder Inc., Parasym Ltd., Cerebral Inc., Cerbomed GmbH, Neuvana LLC, Nevro Corp., NeuroPace Inc

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Implantable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-invasive (tVNS) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epileptic Seizures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Obesity Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Depression and Anxiety Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY BIOMATERIAL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Biomaterial
• 6.2. Ceramics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Metallic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Polymeric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VAGUS NERVE STIMULATOR MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Biomaterial
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Biomaterial
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Biomaterial
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Biomaterial
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Biomaterial
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VAGUS NERVE STIMULATOR INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 ReShape Lifesciences Inc
  • 10.2.2 LivaNova LLC
  • 10.2.3 ElectroCore Inc
  • 10.2.4 MicroTransponder Inc
  • 10.2.5 Parasym Ltd
  • 10.2.6 Cerebral Inc
  • 10.2.7 Cerbomed GmbH
  • 10.2.8 Neuvana LLC
  • 10.2.9 Nevro Corp
  • 10.2.10 NeuroPace Inc